drugset / Trial / NCT02775240
Study of SHP620 (Maribavir) in Healthy Adults
Non-randomizedParallel-groupOpen-labelBasic science
Summary
The purpose of this study is to determine how an investigational treatment (maribavir) is handled by the body when administered with two already approved drugs (digoxin and dextromethorphan). The study will also look at the safety and tolerability when maribavir is coadministered with digoxin and dextromethorphan versus digoxin and dextromethorphan alone.
Timeline
- Start
- 2016-07-21
- Primary completion
- 2016-09-12
- Completion
- 2016-09-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Dextromethorphan | Unknown | 30 mg | Oral |
| Subject | Digoxin | Other / unclassified | 0.5 mg | Oral |
| Subject | Maribavir | Small molecule | 400 mg | Oral |